Tue, November 16, 2021

Nathan Weinstein Maintained (VNRX) at Strong Buy with Decreased Target to $9 on, Nov 16th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-9-on-nov-16th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Nathan Weinstein of Aegis Capital, Maintained "VolitionRx Limited" (VNRX) at Strong Buy with Decreased Target from $10 to $9 on, Nov 16th, 2021.

Nathan, nor any peers, have made any analyst calls on VNRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30